#United States #Houston #DermiSphere #Fesarius Therapeutics #hDRT

Fesarius Therapeutics Showcases DermiSphere™ hDRT at 2026 Plastic Surgery Meeting

Fesarius Therapeutics, an innovative medical technology company focused on dermal repair, is excited to announce its participation in the highly anticipated Plastic Surgery The Meeting (PSTM) 2026. This prestigious event will be hosted from October 15 to 18 at the George R. Brown Convention Center in Houston, Texas. Here, Fesarius will prominently feature its cutting-edge product, DermiSphere™ hDRT, which stands as the first and only dual-density collagen hydrogel dermal regeneration template.

DermiSphere™ hDRT is engineered to create a dual-density scaffold, fostering tissue integration, promoting rapid vascularization, and encouraging the formation of new tissue. Attendees at PSTM can visit the Fesarius team at booth #1920 to learn more about the application of DermiSphere™ hDRT in various clinical settings.

Scientific Symposium and Keynote Events

In conjunction with PSTM, Fesarius will host a scientific symposium titled "From Benchtop to Bedside - Advancing Dermal Regeneration with Hydrogel Technology" on Saturday, October 17, 2026, from 3:30 PM to 4:30 PM CDT. This session will be held in the CC, Innovation Theater B, located within the Exhibit Hall DE. The symposium will delve into the foundational principles of DermiSphere™ hDRT, emphasizing its dual-density microarchitecture, its clinical applications, and exploring emerging data and surgeon experiences in complex wound and reconstructive cases.

Renowned experts in the field will present at the symposium, including Jason Spector, MD, who is the Chief Medical Officer at Fesarius and Chief of the Division of Plastic Reconstructive Surgery at Weill Cornell Medicine, as well as Brendan MacKay, MD, Associate Professor of Orthopedic Surgery at Texas Tech University Health Sciences Center. This gathering promises to be an invaluable opportunity for professionals in the plastic surgery community to engage with leading minds and learn about the advancements in dermal regeneration.

Happy Hour Expert Panel Discussion

Following the symposium, Fesarius will also participate in an engaging expert panel discussion accompanied by a happy hour, titled "Connecting Plastic Surgery, Innovation, and Investment." Scheduled for Saturday, October 17, 2026, from 6:30 PM to 8:00 PM at the Hilton Hotel, Houston, the event will be hosted by ASPS Ventures. This unique panel will include Fesarius President and CEO Tom Roueche, bringing together surgeons, innovators, and investors dedicated to advancing medical technology that addresses unfulfilled clinical needs.

About Fesarius Therapeutics

Fesarius Therapeutics is dedicated to revolutionizing dermal repair through innovative biomaterials, with its flagship product DermiSphere™ hDRT exemplifying this mission. Developed from pioneering research by plastic surgeon Jason Spector at Weill Cornell Medicine, this product represents a significant breakthrough in supporting the body's natural healing processes. By blending a collagen hydrogel with denser collagen microspheres, DermiSphere™ hDRT aims to facilitate dermal tissue regeneration effectively.

For more information about Fesarius Therapeutics and their participation in PSTM 2026, please visit the company’s official website at Fesarius Therapeutics.

Conclusion

The Plastic Surgery Meeting 2026 is set to be a pivotal moment for industry professionals, offering insights into the latest innovations in dermal repair technologies. Fesarius Therapeutics is making significant strides in this field, and its presence at the event will surely ignite discussions on future advancements in plastic surgery.

Stay tuned for updates and insights from this exceptional event as Fesarius continues to lead the way in reimagining dermal repair.